Hints and tips:
Related Special Reports
...EU regulators have delayed a decision to approve Novavax’s variant-tailored Covid-19 vaccine, in a setback for the US-listed biotech which is battling a slump in demand for coronavirus jabs....
...The investors suing Apple claimed that Cook had downplayed concerns about China, citing a “strong” recent quarter in the region....
...Cook and Apple have been keen to turn around the narrative....
...Cook also visited Vietnam and Indonesia over the past week for talks on possible expansion of production....
...“Pain could be analogous to another GLP-1 scenario,” says Hartaj Singh, a biotech analyst at equity research company Oppenheimer — referring to the hormone targeted by the weight-loss drugs....
...Apple will release its Vision Pro headset to consumers in the US on Friday, in a test of chief executive Tim Cook’s ability to create a groundbreaking product with mass appeal that can power a new phase...
...Shah called for Suresh Katta and Venkat Peri, both chief executives of other biotechs, to be nominated for the independent board roles....
...It says it needs improved access to capital, but it claims to be one of the largest biotech fundraisers in recent years....
Advocate general of bloc’s top court says decision against world’s biggest gene sequencing group should be annulled
...On a busy day at work in 2016, Matthew Panuwat took a break from his biotech executive job to make a stock trade on his computer....
...Lawyers for the DRC government have written to Apple chief executive Tim Cook with a series of questions in a letter dated April 22 and seen by the Financial Times....
...But Amyris had also branched out into being an incubator for beauty start-ups including Rose Inc, Costa Brazil and JVN hair care, and it proved too huge a leap from developing molecules to developing brands...
...As the US unveiled the lawsuit on Thursday, chief executive Tim Cook was in Shanghai for a public relations offensive....
...Cook said the Vision Pro launch in the US would be followed by “expansion to other countries later this year”....
...A group of Wall Street traders maliciously drove down the share price of a Maryland biotech with a promising new brain cancer vaccine, in pursuit of the marginal profits to be made by buying the stock cheaply...
...EU regulators will order US biotech Illumina to sell cancer test developer Grail after it bought the $8bn company without the approval of Brussels, according to three people with direct knowledge of the...
...The German biotech group said on Monday that it had been informed by Pfizer that the majority of the write-offs related to raw materials purchased during the pandemic, mainly the lipids that deliver the...
...Illumina has appointed Jacob Thaysen as its new chief executive, as the biotech group seeks to rebuild its leadership team following a bruising battle with activist investor Carl Icahn....
...Cook stunned a senior BMW executive by saying that the iPhone-maker could, in fact, turn its hand to replicating the carmaker’s engineering and production capacity. He was wrong....
...Tim Cook, Apple’s chief executive, is visiting Vietnam this week as the iPhone maker plans to increase its supply chain there....
...Need to know: business Novo Nordisk announced a €1bn deal for a German biotech developing therapies to treat heart disease, as the Danish group seeks to branch out from its blockbuster diabetes and weight...
...Generative AI is sweeping through the tech world and Cook, as chief executive, needs to rally the troops....
...Cook talked up Apple’s growing investment in generative AI, and hinted at a major announcement in that area later this year....
...Cook could hardly be accused of sitting on his hands. On his watch, Apple’s research and development intensity has mounted steadily....
...Chief executive Tim Cook last month told analysts he remained “very optimistic about China over the long term” and blamed part of the decline on a stronger dollar....
International Edition